Nerve function impairment in leprosy: design, methodology, and intake status of a prospective cohort study of 2664 new leprosy cases in Bangladesh (The Bangladesh Acute Nerve Damage Study)

Citation
Rp. Croft et al., Nerve function impairment in leprosy: design, methodology, and intake status of a prospective cohort study of 2664 new leprosy cases in Bangladesh (The Bangladesh Acute Nerve Damage Study), LEPROSY REV, 70(2), 1999, pp. 140-159
Citations number
33
Categorie Soggetti
Dermatology
Journal title
LEPROSY REVIEW
ISSN journal
03057518 → ACNP
Volume
70
Issue
2
Year of publication
1999
Pages
140 - 159
Database
ISI
SICI code
0305-7518(199906)70:2<140:NFIILD>2.0.ZU;2-J
Abstract
The Bangladesh Acute Nerve Damage Study (BANDS) is a prospective cohort stu dy designed to investigate epidemiological, diagnostic, therapeutic and ope rational aspects of acute nerve function impairment in leprosy. The study i s based at a single centre in Bangladesh, in an area with a high prevalence of leprosy. The centre, Danish Bangladesh Leprosy Mission, has a well-esta blished vertical leprosy control programme. In this paper, the study design and methodology are described, together with definitions of nerve function impairment (NFI)used in this and subsequent papers. The study recruited 26 64 new leprosy cases in a 12-month period. The male:female ratio is 1.25:1, and 17.61% of the cohort are under 15 years of age. Ln all, 83.33% of the cohort are paucibacillary (PB), and 16.67% multibacillary (MB). However, th e MB rate amongst males is 19.72%, and amongst females is 12.85%, despite a n equal period of delay to diagnosis. 55% of patients presented for treatme nt within 12 months of developing symptoms. 6.12% of the total number of ca ses were smear positive, and 36.71% of the MB cases were smear positive. 9. 61% of the total number of cases were graded as having World Health Organis ation (WHO) disability grade 1, and 5.97% had grade 2. Amongst MB cases, 27 .48% had WHO grade 1 disability present, and 18.24% had grade 2 present, co mpared with 6.04% and 3.51%, respectively, amongst PB cases. A total of 11. 90% of the cohort had sensory NFI of any kind, and 7.39% had motor NFI. Nin ety patients presented with NFI needing treatment (3.38%), and of these, 61 (67.78%) had silent NFI. MB patients had a prevalence of reaction/NFI need ing treatment nearly 7 times higher than PB cases (15.32% amongst MB; 2.30% amongst PB), and males nearly double that of females (5.67% amongst males, 2.96% amongst females). The most commonly affected nerve by function impai rment was the posterior tibial (sensory) with 6.46% of nerves affected (9.3 8% of patients), followed by the ulnar nerve with 3.23% of nerves impaired (5.56% of patients). Future research and publications, building on this fou ndation, will focus on the following areas: thr incidence of NFI and reacti ve events, the risk factors for developing NFI, and the response to treatme nt of patients developing acute NFI.